--- title: eConsent Services | Clinixir description: eConsent utilizes digital platforms or software to deliver vital information to participants and enable them to provide their consent electronically, often through online interfaces. image: https://clinixir.com/hubfs/Clinix_Meta%20Image-wide.png --- [![CLX_Logo-White](https://clinixir.com/hs-fs/hubfs/Logo/CLX_Logo-White.png?width=193&height=40&name=CLX_Logo-White.png "CLX_Logo-White")](https://clinixir.com) [![CLX_Logo-Default](https://clinixir.com/hs-fs/hubfs/Logo/CLX_Logo-Default.png?width=169&height=35&name=CLX_Logo-Default.png "CLX_Logo-Default")](https://clinixir.com/) - [Services](https://clinixir.com/services) - [Clinical Trial Management](https://clinixir.com/services/clinical-trail) - [Regulatory Affairs](https://clinixir.com/services/regulatory-affairs) - [Sponsor’s Local Representative & IOR Services](https://clinixir.com/services/sponsor-local-representative-ior) - [Pharmacovigilance](https://clinixir.com/services/pharmacovigilance) - [Biometrics](https://clinixir.com/services/biometrics) - [Site Management Organization](https://clinixir.com/services/site-management-organization) - [Real World Evidence](https://clinixir.com/services/real-world-evidence) - [Data ConneX](https://clinixir.com/services/dataconnex) - [About Us](https://clinixir.com/about-us) - [Our Partners](https://clinixir.com/about-us#our-partners) - [Our Vision and Mission](https://clinixir.com/about-us#vision) - [Board of Directors](https://clinixir.com/about-us#board) - [Updates](https://clinixir.com/blog) - [Careers](https://clinixir.com/careers) - [Contact Us](https://clinixir.com/contact-us) - [Partner Site Network](https://clinixir.com/contact-us#partner-site) [Email Us](mailto:enquiries@clinixir.com) [Email Us](mailto:enquiries@clinixir.com) [Email Us](mailto:enquiries@clinixir.com) More results - [Services](https://clinixir.com/services) - [Clinical Trial Management](https://clinixir.com/services/clinical-trail) - [Regulatory Affairs](https://clinixir.com/services/regulatory-affairs) - [Sponsor’s Local Representative & IOR Services](https://clinixir.com/services/sponsor-local-representative-ior) - [Pharmacovigilance](https://clinixir.com/services/pharmacovigilance) - [Biometrics](https://clinixir.com/services/biometrics) - [Site Management Organization](https://clinixir.com/services/site-management-organization) - [Real World Evidence](https://clinixir.com/services/real-world-evidence) - [Data ConneX](https://clinixir.com/services/dataconnex) - [About Us](https://clinixir.com/about-us) - [Our Partners](https://clinixir.com/about-us#our-partners) - [Our Vision and Mission](https://clinixir.com/about-us#vision) - [Board of Directors](https://clinixir.com/about-us#board) - [Updates](https://clinixir.com/blog) - [Careers](https://clinixir.com/careers) - [Contact Us](https://clinixir.com/contact-us) - [Partner Site Network](https://clinixir.com/contact-us#partner-site) [Email Us](mailto:enquiries@clinixir.com) # eConsent eConsent utilizes digital platforms or software to deliver vital information to participants and enable them to provide their consent electronically, often through online interfaces. [Request RFP Form](https://clinixir.com/contact-us/rfp) ### Digitizing the Consent Process for Modern Clinical Trials eConsent transforms how participants engage with research studies by allowing them to review information and provide informed consent electronically. Through secure digital platforms—accessible via tablets, desktops, or mobile devices—eConsent enhances participant understanding, streamlines workflows, and strengthens compliance. **Clinixir offers full-service support for eConsent implementation, helping sponsors integrate efficient, regulator-ready digital consent processes into their clinical trials.** ![Clinix_Service-03](https://clinixir.com/hs-fs/hubfs/Image%20Stock/Clinix_Service-03.png?width=800&height=600&name=Clinix_Service-03.png) ## What We Offer Protocol review and feedback to identify potential clinical or operational challenges Site and investigator recommendations based on real-world insights ### [Therapeutic area alignment with standard of care and treatment pathways](https://clinixir.com/services/pharmacovigilance) Feasibility guidance on patient population and recruitment strategies Expert input during study planning and proposal development ## Why eConsent Matters to Sponsors Sponsors benefit from eConsent in several critical ways: **Real-time tracking of participant consent status across sites** Real-time tracking of participant consent status across sites **Greater regulatory compliance with GCP, ICH, and data privacy standards** Greater regulatory compliance with GCP, ICH, and data privacy standards **Reduced delays from missing or outdated consent documentation** Reduced delays from missing or outdated consent documentation **Improved audit readiness with version control and time-stamped records** Improved audit readiness with version control and time-stamped records **Enhanced participant experience, leading to better retention** Enhanced participant experience, leading to better retention --- ## What Makes an Effective eConsent Solution? Choosing the right eConsent system is about more than just digital signatures. It must align with your trial’s operational needs, site workflows, and regulatory requirements. At Clinixir, we work with you to evaluate, implement, and optimize the right solution. #### Participant-Friendly Interface We prioritize platforms that are intuitive and accessible, allowing participants to review and sign consent forms with clarity and ease. #### Seamless Workflow Integration Our team ensures the selected eConsent solution integrates smoothly with existing site operations, reducing administrative workload and tracking errors. #### Regulatory & Ethical Compliance All platforms supported by Clinixir meet GCP, ICH, and local data protection standards, ensuring compliance from start-up to close-out ## eConsent Implementation Services End-to-end support can help ensure eConsent adoption is smooth and effective. Services may include: **Vendor/platform selection and coordination** Vendor/platform selection and coordination **Site onboarding and training** Site onboarding and training **Centralized monitoring of consent metrics** Centralized monitoring of consent metrics **Troubleshooting and technical assistance** Troubleshooting and technical assistance **Integration with CTMS, EDC, and other systems** Integration with CTMS, EDC, and other systems ## Receive a Detailed Project Proposal. Whether for a single-site study or a multi-country trial, eConsent offers a modern, efficient, and compliant way to manage participant consent. [Submit RFP form](https://clinixir.com/contact-us/rfp) ## Areas of Expertise Clinixir brings operational excellence and regulatory insight to a broad range of therapeutic areas. With strong site partnerships, deep regional understanding, and experience supporting both global and local sponsors, we help deliver high-quality, efficient trials across Thailand. Our services span from early-phase planning to post-approval support—tailored to the specific demands of each therapeutic area. ![asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office 1-1](https://clinixir.com/hs-fs/hubfs/asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png?width=600&height=600&name=asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png) ### Oncology Oncology trials are among the most complex and resource-intensive in clinical research. Clinixir supports sponsors with full-service project management, access to leading cancer centers, and collaboration with top-tier oncologists across Thailand. Our ability to navigate evolving regulatory requirements and manage long-term, data-heavy studies ensures trials are conducted with precision and compliance. ![discussing-data-laptop-screen 1](https://clinixir.com/hs-fs/hubfs/discussing-data-laptop-screen%201.png?width=600&height=600&name=discussing-data-laptop-screen%201.png) ### Metabolic Diseases Thailand faces a growing burden of metabolic disorders, making it an ideal environment for studying treatments for conditions such as diabetes, obesity, and NASH. Clinixir works closely with experienced investigators and urban hospital networks to deliver trials that reflect local disease prevalence. We bring proven strategies for protocol adaptation, lifestyle-related variable management, and data-driven decision-making. ![close-up-people-studying-language 1-1](https://clinixir.com/hs-fs/hubfs/close-up-people-studying-language%201-1.png?width=600&height=600&name=close-up-people-studying-language%201-1.png) ### Infectious Diseases With its tropical climate and diverse patient population, Thailand is well-positioned for infectious disease research, including dengue, COVID-19, hepatitis, and tuberculosis. Clinixir leverages strong public-private site partnerships and a responsive regulatory framework to support fast-start trials and high-volume enrollment. Our local insight is key in managing outbreak-related studies and public health-focused research. ![asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office 1-1](https://clinixir.com/hs-fs/hubfs/asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png?width=600&height=600&name=asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png) ### Herbal Medicines As a region rich in traditional medicine, Thailand offers unique opportunities for evidence-based research on herbal and botanical therapies. Clinixir provides expertise in designing studies that meet international standards while respecting local practices. We work closely with academic institutions and regulatory bodies to ensure product safety, consistency, and scientific validity throughout the research process. ![discussing-data-laptop-screen 1](https://clinixir.com/hs-fs/hubfs/discussing-data-laptop-screen%201.png?width=600&height=600&name=discussing-data-laptop-screen%201.png) ### Rare Diseases Conducting rare disease trials requires specialized recruitment strategies and high coordination across stakeholders. Clinixir helps sponsors overcome challenges in patient identification and retention by leveraging Thailand’s academic networks and referral systems. We also support early engagement with regulatory authorities to streamline study approvals and orphan drug considerations. ![close-up-people-studying-language 1-1](https://clinixir.com/hs-fs/hubfs/close-up-people-studying-language%201-1.png?width=600&height=600&name=close-up-people-studying-language%201-1.png) ### Medical Devices Device trials require tailored protocols, usability evaluations, and precise regulatory alignment. Clinixir supports both diagnostic and therapeutic device studies, from feasibility through post-marketing. Our familiarity with Thailand’s Medical Device Control Division and hands-on experience managing combination product trials allows us to guide sponsors through compliant and efficient development. ![asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office 1-1](https://clinixir.com/hs-fs/hubfs/asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png?width=600&height=600&name=asia-businessmen-businesswomen-meeting-brainstorming-ideas-conducting-business-presentation-project-colleagues-working-together-plan-success-strategy-enjoy-teamwork-small-modern-office%201-1.png) ### Neurology Neurological research demands careful site selection, complex endpoint monitoring, and long-term follow-up. Clinixir supports trials in Alzheimer’s, Parkinson’s, epilepsy, and neurodevelopmental disorders, with access to leading neurologists and specialist centers. We focus on ensuring data quality and patient continuity throughout lengthy trial durations, while maintaining adherence to global best practices. ![Clinix_About us-05](https://clinixir.com/hs-fs/hubfs/Clinix_About%20us-05.png?width=800&height=1024&name=Clinix_About%20us-05.png) ### Other Therapeutic Areas Clinixir actively supports clinical trials in advanced and evolving therapeutic areas, including cell and gene therapies such as CAR-T cell therapy. These studies demand complex regulatory navigation, specialized site coordination, and high standards of operational execution—all areas where our team delivers with confidence. We remain open and responsive to supporting sponsors working in innovative or highly specialized fields beyond traditional trial models. With strong institutional partnerships, experienced project teams, and a flexible operational framework, Clinixir is well-positioned to adapt to new study designs and cutting-edge therapies as they emerge. As the clinical research landscape evolves, we continue to expand our capabilities to meet the future of medicine.   Oncology Metabolic Diseases Infectious Diseases Herbal Medicines Rare Diseases Medical Devices Neurology Other Therapeutic Areas [See More Our Services](https://clinixir.com/services) ## Areas of Expertise Clinixir brings operational excellence and regulatory insight to a broad range of therapeutic areas. With strong site partnerships, deep regional understanding, and experience supporting both global and local sponsors, we help deliver high-quality, efficient trials across Thailand. Our services span from early-phase planning to post-approval support—tailored to the specific demands of each therapeutic area. - ### Oncology ![Mask group-2](https://clinixir.com/hs-fs/hubfs/Mask%20group-2.png?width=875&height=353&name=Mask%20group-2.png) Oncology trials are among the most complex and resource-intensive in clinical research. Clinixir supports sponsors with full-service project management, access to leading cancer centers, and collaboration with top-tier oncologists across Thailand. Our ability to navigate evolving regulatory requirements and manage long-term, data-heavy studies ensures trials are conducted with precision and compliance. - ### Metabolic Diseases ![Mask group-1](https://clinixir.com/hs-fs/hubfs/Mask%20group-1.png?width=875&height=353&name=Mask%20group-1.png) Thailand faces a growing burden of metabolic disorders, making it an ideal environment for studying treatments for conditions such as diabetes, obesity, and NASH. Clinixir works closely with experienced investigators and urban hospital networks to deliver trials that reflect local disease prevalence. We bring proven strategies for protocol adaptation, lifestyle-related variable management, and data-driven decision-making. - ### Infectious Diseases ![Mask group-7-1](https://clinixir.com/hs-fs/hubfs/Mask%20group-7-1.png?width=875&height=353&name=Mask%20group-7-1.png) With its tropical climate and diverse patient population, Thailand is well-positioned for infectious disease research, including dengue, COVID-19, hepatitis, and tuberculosis. Clinixir leverages strong public-private site partnerships and a responsive regulatory framework to support fast-start trials and high-volume enrollment. Our local insight is key in managing outbreak-related studies and public health-focused research. - ### Herbal Medicines ![Mask group-6](https://clinixir.com/hs-fs/hubfs/Mask%20group-6.png?width=875&height=353&name=Mask%20group-6.png) As a region rich in traditional medicine, Thailand offers unique opportunities for evidence-based research on herbal and botanical therapies. Clinixir provides expertise in designing studies that meet international standards while respecting local practices. We work closely with academic institutions and regulatory bodies to ensure product safety, consistency, and scientific validity throughout the research process. - ### Rare Diseases ![Mask group-4](https://clinixir.com/hs-fs/hubfs/Mask%20group-4.png?width=875&height=353&name=Mask%20group-4.png) Conducting rare disease trials requires specialized recruitment strategies and high coordination across stakeholders. Clinixir helps sponsors overcome challenges in patient identification and retention by leveraging Thailand’s academic networks and referral systems. We also support early engagement with regulatory authorities to streamline study approvals and orphan drug considerations. - ### Medical Devices ![Mask group](https://clinixir.com/hs-fs/hubfs/Mask%20group.png?width=875&height=353&name=Mask%20group.png) Device trials require tailored protocols, usability evaluations, and precise regulatory alignment. Clinixir supports both diagnostic and therapeutic device studies, from feasibility through post-marketing. Our familiarity with Thailand’s Medical Device Control Division and hands-on experience managing combination product trials allows us to guide sponsors through compliant and efficient development. - ### Neurology ![Mask group-7](https://clinixir.com/hs-fs/hubfs/Mask%20group-7.png?width=875&height=353&name=Mask%20group-7.png) Neurological research demands careful site selection, complex endpoint monitoring, and long-term follow-up. Clinixir supports trials in Alzheimer’s, Parkinson’s, epilepsy, and neurodevelopmental disorders, with access to leading neurologists and specialist centers. We focus on ensuring data quality and patient continuity throughout lengthy trial durations, while maintaining adherence to global best practices. - ### Other Therapeutic Areas ![Mask group-1](https://clinixir.com/hs-fs/hubfs/Mask%20group-1.png?width=875&height=353&name=Mask%20group-1.png) Clinixir actively supports clinical trials in advanced and evolving therapeutic areas, including cell and gene therapies such as CAR-T cell therapy. These studies demand complex regulatory navigation, specialized site coordination, and high standards of operational execution—all areas where our team delivers with confidence. We remain open and responsive to supporting sponsors working in innovative or highly specialized fields beyond traditional trial models. With strong institutional partnerships, experienced project teams, and a flexible operational framework, Clinixir is well-positioned to adapt to new study designs and cutting-edge therapies as they emerge. As the clinical research landscape evolves, we continue to expand our capabilities to meet the future of medicine. [See More Our Services](https://clinixir.com/services) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-CMU-02.png?width=1200&length=1200&name=Clinix_Uni-CMU-02.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-CU-02.png?width=1200&length=1200&name=Clinix_Uni-CU-02.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-Khonkaen.png?width=1200&length=1200&name=Clinix_Uni-Khonkaen.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-MU-Rama.png?width=1200&length=1200&name=Clinix_Uni-MU-Rama.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-MU-Srisirat.png?width=1200&length=1200&name=Clinix_Uni-MU-Srisirat.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-MU-Tropical.png?width=1200&length=1200&name=Clinix_Uni-MU-Tropical.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-Songkla.png?width=1200&length=1200&name=Clinix_Uni-Songkla.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-TU.png?width=1200&length=1200&name=Clinix_Uni-TU.png) ![](https://242299077.fs1.hubspotusercontent-na2.net/hub/242299077/hubfs/Logo/Clinix_Uni-Ubon.png?width=1200&length=1200&name=Clinix_Uni-Ubon.png) > "I am very pleased to update everyone that the First Country Subject has been enrolled by Thailand Team on 11 October 2023 at site THA-764-002! After all from the start up process up to getting the approval, trainings, documentations, we have finally made it. I know this is not easy, So I want to take this opportunity to give thanks to the site, Clinixir and to the AZ Thailand study team for your hard work!" Darwelle Manalang Clinical Project Manager, AstraZeneca (Thailand) Ltd. ![astrazeneca_icon-logo_brandlogos.net_iuwml](https://clinixir.com/hs-fs/hubfs/astrazeneca_icon-logo_brandlogos.net_iuwml.png?width=54&height=65&name=astrazeneca_icon-logo_brandlogos.net_iuwml.png) > “Tech Observer would like to thank Clinixir for your close collaboration with the sponsor and us during the recent PY8 application process. Your diligent efforts in supporting the sponsor and coordinating with the sites to obtain the necessary documents for PY8 are commendable. Additionally, Clinixir's attendance for a telephone conference with the sponsor on short notice is highly appreciated. The sponsor is deeply thankful for your dedication and support. Thank you.!” Peng Chan Director, Tech Observer Asia Pacific Pte. Ltd. ![fggf](https://clinixir.com/hs-fs/hubfs/fggf.png?width=145&height=40&name=fggf.png) > “I am delighted to hear the news and I extend my heartfelt congratulations to each one of your team for reaching this milestone. It reflects the dedication and hard work put forth through exceptional teamwork. Let us carry forward the momentum, enthusiasm, and collaborative spirit to achieve the upcoming milestones. Great job team.” Dr. Arun Mohan Sr. Clinical Project Manager ,Tech Observer Asia Pacific Pte. Ltd. ![fggf](https://clinixir.com/hs-fs/hubfs/fggf.png?width=150&height=41&name=fggf.png) > “We are highly impressed with Clinixir's team, whose professionalism and expertise have greatly contributed to the success of our project.” Suleeporn Pisitthakarn Great Eastern Drug Co.,Ltd. ![ged](https://clinixir.com/hs-fs/hubfs/Logo/ged.png?width=103&height=50&name=ged.png) > “The Sponsor extends their gratitude to K Purada and the Clinixir CRAs/CTA for their invaluable assistance and dedication in successfully cleaning and locking the ChulaVac006 database for the project's interim analysis as planned on February 16, 2024. Your efforts are greatly appreciated.” Suttipong Chinkrua Project Manager, Freelance ![Favi_White](https://clinixir.com/hs-fs/hubfs/Logo/Favi_White.png?width=70&height=70&name=Favi_White.png) > “Thank you for your kind support in ensuring the cleaning and locking of the ChulaVac006 interim analysis database as planned. The sponsor greatly appreciates your dedication.Suttipong Chinkrua.” Suttipong Chinkrua Project Manager, Freelance ![Favi_White](https://clinixir.com/hs-fs/hubfs/Logo/Favi_White.png?width=70&height=70&name=Favi_White.png) > "On behalf of Aestema, I would like to express our sincere appreciation for your continuous support and dedication throughout the Thai FDA registration process. Your cooperation and prompt assistance have been instrumental in achieving this important milestone. Thank you once again for your excellent support." Jadsada Chailangka (Sunday) Owner Representative, Head of CEO office ![209208](https://clinixir.com/hs-fs/hubfs/209208.webp?width=162&height=162&name=209208.webp) ## Subscribe to Our Monthly Newsletter Sign up to our monthly newsletter to get the latest news and updates delivered directly in your inbox ![CLX_Logo-Default](https://clinixir.com/hs-fs/hubfs/Logo/CLX_Logo-Default.png?width=206&height=46&name=CLX_Logo-Default.png) [173/18 Asia Centre Building, 17th Floor S Sathorn Rd, Sathon, Bangkok 10120](https://maps.app.goo.gl/XbLGN49iWPSFS1J67) [Download Our Company Booklet](https://clinixir.com/hubfs/Clinixir%20E-Booklet%20-%2009.10.24%201.pdf)  [enquiries@clinixir.com](mailto:enquiries@clinixir.com) [02-163-6430](tel:%2002-163-6430)   02-163-6432 © Copyright 2026 Clinixir All rights reserved. [Privacy Policy](https://clinixir.com/privacy-policy-clinixir) [![Social 01](https://clinixir.com/hs-fs/hubfs/Social%2001.png?width=318&height=313&name=Social%2001.png)](https://www.linkedin.com/company/clinixir/?originalSubdomain=th) [![Social 02](https://clinixir.com/hs-fs/hubfs/Social%2002.png?width=318&height=313&name=Social%2002.png)](https://www.facebook.com/clinixirthailand/) [![Social 03](https://clinixir.com/hs-fs/hubfs/Social%2003.png?width=318&height=313&name=Social%2003.png)](mailto:enquiries@clinixir.com)